Pharmaceutical company Hikma now offers its vital products to Middle East and North AfricaHikma Pharmaceuticals PLC (Hikma) has announced its new licensing agreement with Takeda Pharmaceuticals to expand its distribution and products to the Middle East and North Africa (MENA). “We are pleased to be building on our partnership with Takeda to bring important medicines to the MENA region. The new agreement will build on a long-term strategic relationship between Hikma and Takeda, leveraging Hikma’s substantial sales and manufacturing presence in MENA and extensive experience of building brands in the region. A spokesman for Takeda commented: “We put patients at the centre of everything we do. As such, our partnership with Hikma is a testament of our commitment to offer patients world-class cardiovascular and metabolism medicines while keeping focus on our therapeutic areas of oncology and gastroenterology.”

Source: The North Africa Journal August 17, 2017 06:56 UTC